Procter & Gamble reported Q1 results in line with expectations, reaffirmed its 2014 guidance, and highlighted strong cost-saving measures and strategic growth initiatives in developing markets. While there are headwinds from foreign exchange and some market challenges, the overall outlook remains stable with positive long-term prospects. This balanced report is likely to have a modest positive effect on the stock in the short term.

[1]